Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide in Adult Participants With IBS-C
NCT07545772Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2026
- Primary completion
- Jul 2027
- Modality
- Peptides
- Countries
- 8
01
Overview
A Phase 2 trial of brenipatide in irritable bowel syndrome (IBS), sponsored by Eli Lilly and Company. Started Apr 2026; status: recruiting.
02
Drugs
brenipatide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT07545772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545772.